← Open Payments lookup

ANGELA ALESI: Open Payments

NPI 1760411318 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,711 in 112 payments from 17 companies in 2025. Trend: 2023 $1,101 · 2024 $1,651 · 2025 $2,711

Food & beverage: $2,711
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$593
Neurocrine BioSciences, Inc.9$315
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$251
ABBVIE INC.8$239
Vanda Pharmaceuticals Inc.7$226
Alkermes, Inc.9$218
Axsome Therapeutics, Inc.5$105
Almatica Pharma LLC6$102
Takeda Pharmaceuticals U.S.A., Inc.4$100
Teva Pharmaceuticals USA, Inc.4$97

Products named: REXULTI, INGREZZA, CAPLYTA, FANAPT, VRAYLAR, ARISTADA, Auvelity, LOREEV XR.

Industry payments across NV — which companies pay providers there.